114 related articles for article (PubMed ID: 29605690)
1. Lack of evidence of association between IFNG and IL28B polymorphisms and QuantiFERON-CMV test results in seropositive transplant patients.
Aguado R; Páez-Vega A; Agüera ML; Montejo M; Guirado L; Fortún J; Suárez-Benjumea A; Len O; Fariñas MC; de Gracia C; Hernández D; Cobos-Ceballos MJ; Torre-Cisneros J; Cantisán S; ;
Hum Immunol; 2018 Jun; 79(6):499-505. PubMed ID: 29605690
[TBL] [Abstract][Full Text] [Related]
2. Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG+ response.
Páez-Vega A; Poyato A; Rodriguez-Benot A; Guirado L; Fortún J; Len O; Abdala E; Fariñas MC; Cordero E; de Gracia C; Hernández D; González R; Torre-Cisneros J; Cantisán S; ;
Antiviral Res; 2018 Jul; 155():97-105. PubMed ID: 29782877
[TBL] [Abstract][Full Text] [Related]
3. Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients.
Annibali O; Piccioni L; Tomarchio V; Circhetta E; Sarlo C; Franceschini L; Cantonetti M; Rizzo E; Angeletti S; Tirindelli MC; Scagnolari C; Statzu M; Avvisati G; Riva E
PLoS One; 2018; 13(7):e0200221. PubMed ID: 30036376
[TBL] [Abstract][Full Text] [Related]
4. IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.
Corrales I; Solano C; Amat P; Giménez E; de la Cámara R; Nieto J; López J; García-Noblejas A; Piñana JL; Navarro D
J Med Virol; 2017 Apr; 89(4):685-695. PubMed ID: 27591738
[TBL] [Abstract][Full Text] [Related]
5. Impact of age and cytomegalovirus on CD8
Cantisán S; Páez-Vega A; Santos F; Rodríguez-Benot A; Aguado R; Rivero A; Montejo M; Torre-Cisneros J; Solana R;
Exp Gerontol; 2017 Sep; 95():98-106. PubMed ID: 28465043
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
Vu D; Shah T; Ansari J; Sakharkar P; Yasir Q; Naraghi R; Hutchinson I; Min D
Transpl Infect Dis; 2014 Oct; 16(5):724-32. PubMed ID: 25208755
[TBL] [Abstract][Full Text] [Related]
7. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.
Castón JJ; Cantisán S; González-Gasca F; Páez-Vega A; Abdel-Hadi H; Illescas S; Alonso G; Torre-Cisneros J
Intensive Care Med; 2016 Jan; 42(1):46-53. PubMed ID: 26537489
[TBL] [Abstract][Full Text] [Related]
8. Prevention strategies differentially modulate the impact of cytomegalovirus replication on CD8(+) T-cell differentiation in high-risk solid organ transplant patients.
Cantisán S; Páez-Vega A; Pérez-Romero P; Montejo M; Cordero E; Gracia-Ahufinger I; Martín-Gandul C; Maruri N; Aguado R; Solana R; Torre-Cisneros J;
Antiviral Res; 2016 Aug; 132():244-51. PubMed ID: 27378225
[TBL] [Abstract][Full Text] [Related]
9. Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact.
Valle-Arroyo J; Aguado R; Páez-Vega A; Pérez AB; González R; Fornés G; Torre-Cisneros J; Cantisán S
Sci Rep; 2020 Apr; 10(1):7194. PubMed ID: 32346028
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
[TBL] [Abstract][Full Text] [Related]
11. Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation.
Manuel O; Wójtowicz A; Bibert S; Mueller NJ; van Delden C; Hirsch HH; Steiger J; Stern M; Egli A; Garzoni C; Binet I; Weisser M; Berger C; Cusini A; Meylan P; Pascual M; Bochud PY;
J Infect Dis; 2015 Mar; 211(6):906-14. PubMed ID: 25301956
[TBL] [Abstract][Full Text] [Related]
12. Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapy.
Zandvliet ML; Falkenburg JH; Jedema I; Willemze R; Guchelaar HJ; Meij P
J Immunother; 2009 Jun; 32(5):513-23. PubMed ID: 19609244
[TBL] [Abstract][Full Text] [Related]
13. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.
Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G
New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
Fleming T; Dunne J; Crowley B
J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
[TBL] [Abstract][Full Text] [Related]
16. Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.
Banas B; Böger CA; Lückhoff G; Krüger B; Barabas S; Batzilla J; Schemmerer M; Köstler J; Bendfeldt H; Rascle A; Wagner R; Deml L; Leicht J; Krämer BK
BMC Immunol; 2017 Mar; 18(1):15. PubMed ID: 28270092
[TBL] [Abstract][Full Text] [Related]
17. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
Lochmanova A; Lochman I; Tomaskova H; Marsalkova P; Raszka J; Mrazek J; Dedochova J; Martinek A; Brozmanova H; Grundmann M
Transplant Proc; 2010 Nov; 42(9):3574-7. PubMed ID: 21094818
[TBL] [Abstract][Full Text] [Related]
18. QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity.
Giulieri S; Manuel O
Expert Rev Mol Diagn; 2011 Jan; 11(1):17-25. PubMed ID: 21171917
[TBL] [Abstract][Full Text] [Related]
19. Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients.
Bravo D; Solano C; Giménez E; Remigia MJ; Corrales I; Amat P; Navarro D
J Med Virol; 2014 May; 86(5):838-44. PubMed ID: 24374819
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus.
Egli A; Levin A; Santer DM; Joyce M; O'Shea D; Thomas BS; Lisboa LF; Barakat K; Bhat R; Fischer KP; Houghton M; Tyrrell DL; Kumar D; Humar A
J Infect Dis; 2014 Sep; 210(5):717-27. PubMed ID: 24620020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
